334
Participants
Start Date
July 23, 2018
Primary Completion Date
January 23, 2020
Study Completion Date
April 26, 2023
Tislelizumab
Administered intravenously
Cisplatin
Administered intravenously
Carboplatin
Administered intravenously
Pemetrexed
Administered intravenously
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
Beijing Cancer Hospital, Beijing
Beijing Hospital, Beijing
Peking Union Medical College Hospital, Beijing
Chinese Pla General Hospital, Beijing
The First Hospital of China Medical University, Shenyang
Liaoning Cancer Hospital and Institute, Shenyang
The First Hospital of Jilin University, Changchun
Harbin Medical University Cancer Hospital, Harbin
Fudan University Shanghai Cancer Center, Shanghai
Shanghai Chest Hospital, Shanghai
The First Affiliated Hospital of Soochow University Branch Shizi, Suzhou
Xuzhou Central Hospital, Xuzhou
Anhui Provincial Hospital, Hefei
Qilu Hospital of Shandong University, Jinan
Jinan Central Hospital, Jinan
Jinan Military General Hospital, Jinan
Shandong Cancer Hospital, Jinan
Weifang Peoples Hospital, Weifang
Tianjin Medical University General Hospital, Tianjin
Tianjin Medical University Cancer Institute and Hospital, Tianjin
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Hangzhou First Peoples Hospital, Hangzhou
Zhejiang University College of Medicine Second Affiliated Hospital, Hangzhou
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Fujian Cancer Hospital, Fuzhou
The First Affiliated Hospital of Xiamen University, Xiamen
The Second Affiliated Hospital of Chongqing Medical University, Chongqing
Daping Hospital, Third Military Medical University, Chongqing
Chongqing Three Gorges Central Hospital, Chongqing
Changsha Central Hospital, Changsha
Hunan Cancer Hospital, Changsha
Hubei Cancer Hospital, Wuhan
Henan Cancer Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Cancer Center of Guangzhou Medical University, Guangzhou
Nanfang Hospital of Southern Medical University, Guangzhou
Cancer Hospital of Shantou University Medical College, Shantou
The Peoples Hospital of Guangxi Zhuang Autonomous Region, Nanning
Affiliated Hospital of Guilin Medical University, Guilin
Guizhou Cancer Hospital, Guiyang
The Affiliated Hospital of Zunyi Medical College, Zunyi
Hainan General Hospital, Haikou
West China Hospital, Sichuan University, Chengdu
Yunnan Cancer Hospital, Kunming
The First Affiliated Hospital of Xian Jiaotong University, Xi'an
Lead Sponsor
BeiGene
INDUSTRY